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Abstract Hepatitis C virus (HCV) glycoproteins E1 and E2
are believed to be retained in the endoplasmic reticulum (ER) or
cis-Golgi compartment via retention signals located in their
transmembrane domains. Here we describe the detection of E1
and E2 at the surface of transiently transfected HEK 293T and
Huh7 cells. Surface-localized E1E2 heterodimers presented ex-
clusively as non-covalently associated complexes. Surface-ex-
pressed E2 contained trans-Golgi modi¢ed complex/hybrid
type carbohydrate and migrated di¡usely between 70 and 90
kDa while intracellular E1 and E2 existed as high mannose
35 kDa and 70 kDa precursors, respectively. In addition, sur-
face-localized E1E2 heterodimers were incorporated into E1E2-
pseudotyped HIV-1 particles that were competent for entry into
Huh7 cells. These studies suggest that functional HCV glyco-
proteins are not retained exclusively in the ER and transit
through the secretory pathway.
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1. Introduction
Hepatitis C virus (HCV) is a positive sense RNA virus and
comprises the hepacivirus genus in the family Flaviviridae.
Approximately 200 million people are chronically infected
with HCV world-wide with infection rates as high as 20% in
some countries. The genome of HCV encodes an approxi-
mately 3300 amino acid polyprotein that is cleaved co- and
post-translationally into structural (core, E1, E2) and non-
structural (NS2, 3, 4, 5a and 5b) proteins. Two small proteins
of unclear function (p7 and F) are also generated from the
polyprotein by distinct mechanisms. The virus cannot be read-
ily propagated in cell culture so studies of the structure and
function of the viral glycoproteins have been limited to het-
erologous systems that utilize transient transfection or infec-
tion with recombinant viruses that express the viral glycopro-
teins [1,2].
The HCV glycoproteins, E1 (polyprotein residues 191^383)
and E2 (384^746), are type 1 transmembrane proteins each
comprising an N-terminal glycosylated ectodomain and C-ter-
minal transmembrane domain (TMD). When expressed in cell
culture systems, E1 and E2 form heterodimers in a TMD
domain-dependent manner [3]. Two forms of E1E2 complexes
can be detected with the use of monoclonal antibodies
(MAbs). Conformation-dependent MAbs immunoprecipitate
E1E2 complexes stabilized by non-covalent interactions
whereas MAbs to linear epitopes also recognize heterogeneous
disul¢de-linked aggregates that are believed to represent mis-
folded complexes destined for degradation [4].
Previous studies investigating the localization of E1 and E2
have indicated that they are retained in the endoplasmic retic-
ulum (ER) due to the presence of static retention signals in
their TMDs and in the juxtamembrane region of E1 [5^8].
Expression of the entire structural region in mammalian and
insect cells results in the formation of HCV-like particles that
remain associated with budding membrane invaginations of
the rough ER and membranous vacuoles [9^11]. Insect cell-
derived HCV-like particles are capable of binding target cells,
however, their ability to mediate membrane fusion, an oblig-
atory step preceding viral entry, has not been demonstrated
[12].
Thus evidence that hepatitis C virions mature through the
trans-Golgi network is lacking despite an observation pointing
to trans-Golgi network modi¢cations of HCV sugar moieties
[13]. Whereas our understanding of HCV maturation is in-
complete, the maturation pathway of £aviviruses, which are
phylogenetically related to HCV, involves the trans-Golgi net-
work [14].
Here we describe the detection of native E1 and E2 ex-
pressed at the cell surface. Cell surface-localized E1E2 exist
as non-covalently associated heterodimers, with surface-local-
ized E2 exhibiting trans-Golgi modi¢ed complex/hybrid type
carbohydrates. Plasma membrane-localized E1E2 hetero-
dimers can be incorporated into retroviral pseudoparticles
and represent a functional form of the glycoproteins mediat-
ing viral entry. These studies suggest that functional HCV
glycoproteins are not retained exclusively in the ER and trans-
it through the secretory pathway.
2. Materials and methods
2.1. Cell lines and antibodies
HEK 293T cells and Huh7 cells were maintained in Dulbecco’s
minimal essential medium containing 10% fetal calf serum and
2 mM L-glutamine (DMF10). MAbs A4, A11 and H53 were a kind
gift from Dr. Jean Dubuisson. Immunoglobulin G was puri¢ed
from plasma obtained from an HCV-infected individual using protein
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G Sepharose (hIgG; Amersham Pharmacia Biotech). MAb 9E10, di-
rected to the myc epitope tag, was puri¢ed from the cell line MYC 1-
9E10.2 using protein G Sepharose (Amersham Pharmacia Biotech).
Mouse MAb speci¢c to calnexin (BD Transduction Laboratories) and
rabbit anti-giantin antibody (Covance Research Products) were used
at 1/500 and 1/2000 dilutions in Western blotting, respectively.
2.2. Vectors
pBRTM/HCV 1-3011con was a generous gift from Dr. C. Rice,
Laboratory of Virology and Infectious Disease, Center for the Study
of Hepatitis C, The Rockefeller University. The full-length infectious
clone pCV-H77c was a generous gift from Dr. J. Bukh and Dr. R.
Purcell, Hepatitis Viruses Section, NIAID, National Institutes of
Health [15]. The HIV-1 luciferase reporter vector NL4-3.LUC.R-E-
was obtained from Dr. N. Landau through the NIH AIDS Research
and Reference Reagent program [16]. pCDNA4HisMax HCV protein
expression vectors were prepared as follows. DNA fragments encod-
ing core (C), E1, E2 and p7 were ampli¢ed using PCR with the prim-
ers Fcore: ggtGGAATTctgatgagcacgaatcctaaacc and p7r: ccTCTAG-
Actcgtgcgtatgcccgctgagg (polyprotein numbering 1^813; pCE1E2p7);
CE1E2 with Fcore and E2r: ccTCTAGActcgcgcctccgcttgggatatgag
(1^746; pCE1E2), E1E2p7 with FE1: ggtGGAATTctggcaacagggaacc-
ttcctgg and p7r (165^813; pE1E2p7), E1E2 with FE1 and E2r (165^
746; pE1E2) from HCV-Hcon. A fragment encoding E1E2 was also
ampli¢ed from pCV-H77c DNA using E1f and E2r to generate the
vector pE1E2H77c. A fragment encoding E2 (363^746) was ampli¢ed
with E2f (ccgGGTACCtccatggtggggaactgg) and E2r to generate pE2.
PCR products were digested with EcoRI and XbaI or KpnI and XbaI
for pE2 and cloned into similarly digested pcDNA4HisMax vector
(Invitrogen). Inserts were fully sequenced on an ABI automated se-
quencer. Vectors were transfected into HEK 293T and Huh7 cells
using Fugene 6 (Roche) according to the manufacturer’s recommen-
dations.
2.3. Immuno£uorescence
Huh7 cells, grown on coverslips, were transfected with plasmid
DNA and Fugene 6 and 24 h later, placed on ice for 30 min. Cells
were either left untreated (un¢xed) or ¢xed in 4% paraformaldehyde
for 20 min and permeabilized in 0.5% Triton X-100 for 1 min. Anti-
body was diluted in FACs bu¡er (phosphate-bu¡ered saline (PBS)
containing 5% bovine serum albumin (BSA), 1 mM EDTA, 0.02%
sodium azide) and added to un¢xed cells or ¢xed and permeabilized
cells, and incubated on ice for 30 min. After three washes, Alexa 488-
conjugated goat anti-mouse antibody diluted in FACs bu¡er was
added to cells and incubated for a further 30 min on ice. After three
further washes, un¢xed cells were ¢xed and coverslips were mounted
in DAKO £uorescence mounting medium and visualized on an Axi-
overt 25 microscope.
2.4. Radioimmunoprecipitation and biotinylation
HEK 293T cells seeded in six-well culture plates at 5U105 cells/well
were transfected 24 h later with plasmid DNA using Fugene 6
Fig. 1. Expression of HCV glycoproteins E1 and E2 in HEK 293T cells transfected with pCE1E2, pCE1E2p7, pE1E2 and pE1E2p7. A: Sche-
matic representation of HCV regions investigated in this study. The numbering refers to the ¢rst or last residue included in each construct.
Cross hatches represent hydrophobic domains incorporating signal peptide and TMDs. B: E1 and E2 glycoproteins were immunoprecipitated
with IgG obtained from an HCV-infected individual (hIgG). Glycoproteins were not treated (UT) or deglycosylated with endoglycosidase H
(H) or PNGase F (F) and followed by reducing SDS^PAGE and phoshorimager analysis. The locations of E1, E2, E2/p7 or deglycosylated
forms (d) are indicated by arrows.
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(Roche). At 24 h post-transfection, the cells were labelled with 150
WCi Tran-35S-label (ICN, Costa Mesa, CA, USA) in methionine/cys-
teine de¢cient medium for 15 min and then chased in complete me-
dium for a further 4 h. Cell lysates were prepared in lysis bu¡er (1%
Triton X-100, 0.05 M Tris^HCl pH 7.4, 0.6 M KCl) and clari¢ed at
10 000Ug for 10 min. In some experiments, cells were treated with
membrane impermeant sulfo-NHS-long chain biotin (Pierce) prior to
lysis. Sulfo-NHS-long chain biotin (1.25 mM in PBS) was added to
cells and incubated on ice for 30 min, washed and then quenched with
50 mM glycine in PBS for 30 min. Proteins were precleared using
Sepharose coupled to BSA for a minimum of 1 h followed by immu-
noprecipitation with protein G Sepharose and antibody. Proteins were
electrophoresed under reducing or non-reducing conditions in SDS^
PAGE followed by electrophoretic transfer to nitrocellulose. Surface-
biotinylated proteins were detected with streptavidin coupled to horse-
radish peroxidase (HRP) and enhanced chemiluminescence (ECL;
Roche). Radiolabelled proteins were visualized by exposing the nitro-
cellulose membrane to a phosphorimager screen after the ECL pro-
cedure.
2.5. Subcellular fractionation
pE1E2-transfected HEK 293T cells were homogenized (1 ml, 250
mM sucrose, 1 mM EDTA, 10 mM Tris^HCl pH 7.4) by passing
through a 25G needle ¢tted to a 1 ml syringe 10 times. The homog-
enate was centrifuged (500Ug, 10 min) and the post-nuclear super-
natant applied to a 10^24% continuous iodixanol (Accudenz) gradient
(3 mM KCl, 5 mM Tris^HCl pH 7.5, 0.3 mM EDTA, 0.75% NaCl)
and centrifuged for 90 min (SW 41, 37 000 rpm). Gradients were
fractionated from the bottom of the tube and proteins precipitated
using methanol/chloroform before analysis on SDS^PAGE and West-
ern blotting.
2.6. E1E2-HIV-1 pseudotype particle entry assay
293T cells seeded at 350 000 cells/well in six-well culture dishes were
transfected with 1 Wg each of NL4-3.LUC.R-E- and either
pE1E2H77c, pCDNA4HisMax or pE2. Three days later, the tissue
culture £uid containing pseudotyped HIV-1 particles was collected,
¢ltered (0.45 Wm) and added to Huh7 cells (30000/well) in 48-well
culture plates. Following 7 h incubation at 37‡C, the inoculum was
removed and the cells cultured for a further 3 days. Luciferase activity
was measured in a Microlumat LB (Berthold) luminometer using the
Promega luciferase reagent system.
3. Results
3.1. Expression of HCV glycoproteins
Previous studies examining the subcellular localization of
E1 and E2 used cells infected with recombinant vaccinia vi-
ruses expressing E1 and E2 [17]. These studies concluded that
the HCV structural proteins are retained in the ER or a cis-
Golgi compartment based on the lack of immuno£uorescent
detection of E1 or E2 at the cell surface, endoglycosidase H
sensitivity of E1 and E2 carbohydrate groups and the colo-
calization of E1 and E2 with ER-resident proteins in subcel-
lular fractionation/immuno£uorescence experiments. In order
to examine E1E2 localization in an expression system that did
not require vaccinia virus infection, we cloned the structural
region of HCV-Hcon (genotype 1a) into the vector pcDNA4-
HisMax (Invitrogen). This cytomegalovirus promoter-driven
expression vector also encodes a translational enhancer for
increased levels of protein expression [18]. HEK 293T cells
were transfected with vectors pCE1E2, pCE1E2p7, pE1E2
or pE1E2p7 (Fig. 1A) and proteins were biosynthetically la-
belled with [35S]Met/Cys. After cell lysis, E1 and E2 were
immunoprecipitated with IgG puri¢ed from the plasma of
an HCV-infected individual (hIgG) and subjected to SDS^
PAGE. Both E1 and E2 were detected for each expression
vector (Fig. 1B, UT). In addition to E2, E2p7 was detected
in vectors encoding CE1E2p7 or E1E2p7 suggesting that co-
or post-translational cleavage at the E2/p7 junction was not
complete. The carbohydrate content of biosynthetically la-
belled E1 and E2 was examined by deglycosylation with en-
doglycosidase H or PNGase F and reducing SDS^PAGE.
After digestion with either enzyme both E1 and E2 were re-
duced to their theoretical backbone molecular weights of 21
kDa and 40 kDa, respectively (Fig. 1B). These results indicate
that E1 and E2 contain high mannose carbohydrate suggestive
of retention in the ER or in a cis-Golgi compartment.
In order to determine if the HCV glycoproteins expressed
from these vectors also exhibit an intracellular localization, we
examined transfected Huh7 cells by immuno£uorescence using
the conformational anti-E2 MAb H53. Unexpectedly, we ob-
served strong cell surface staining for un¢xed pE1E2-trans-
fected Huh7 cells (Fig. 2) under conditions that preclude
staining of the ER-resident chaperone, calnexin (data not
shown). By contrast, ¢xation and permeabilization prior to
staining gave rise to intense perinuclear £uorescence (Fig.
2), in agreement with previous studies [7]. Immuno£uores-
cence was not observed for pE1E2-transfected cells stained
with the control MAb 9E10 nor for control pCDNA4-trans-
fected cells stained with MAb H53 con¢rming that the £uo-
rescence observed is due to a speci¢c interaction between E2
and MAb H53 (Fig. 2). Similar data were obtained for Huh7
cells transfected with pCE1E2, pCE1E2p7 and pE1E2p7 (data
not shown). These results indicate that a signi¢cant propor-
tion of E2 is surface-expressed.
3.2. Subcellular fractionation of E1E2-transfected cells
We next employed iodixanol density gradient centrifugation
in order to determine if E1 and E2 could be detected in non-
Fig. 2. Immuno£uorescence of Huh7 cells transfected with pE1E2
or a control vector, cDNA3. Twenty-four hours after transfection,
cells were placed on ice and stained directly with conformation-de-
pendent E2 speci¢c MAb H53 or irrelevant MAb 9E10 (un¢xed).
Alternatively, cells were ¢xed in 4% paraformaldehyde, permeabi-
lized in 0.1% Triton X-100 before the addition of H53. Bound anti-
body was detected with Alexa 488 goat anti-mouse antibody. Fluo-
rescence was examined using an Axiovert microscope.
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ER compartments. Unlike sucrose, iodixanol allows the sep-
aration of intracellular organelles under isotonic conditions.
pE1E2-transfected HEK 293T cells were homogenized and the
post-nuclear supernatant layered onto 10^24% continuous
iodixanol gradients. Fractions were analyzed for the presence
of the ER-resident protein, calnexin, cis-medial Golgi-resident
protein giantin, E1 (MAb A4) and E2 (MAb A11) using
Western blotting. Fig. 3 shows that the majority of E1 and
E2 sedimented in fractions corresponding to ER. However, we
also observed a small amount of E1 and E2 in low-density
fractions, with a small proportion of E2 migrating in SDS^
PAGE at a higher molecular weight than was observed for the
ER-localized material. This higher molecular weight is sugges-
tive of trans-Golgi oligosaccharide modi¢cations consistent
with a small proportion of E1E2 entering the secretory path-
way.
3.3. Biochemical analysis of HCV proteins expressed at
the cell surface
The results of immuno£uorescence (Fig. 2) and iodixanol
density gradient experiments (Fig. 3) indicate that a small
proportion of total E1E2 escapes the ER and enters the se-
cretory pathway. We therefore employed the sensitive tech-
nique of surface biotinylation in order to ask if we could
directly detect E1 and E2 at the cell surface. To biochemically
compare the total E1 and E2 with the surface-localized com-
ponent, pE1E2H77c-transfected HEK 293T cells were pulse-
chase biosynthetically labelled and then biotinylated with the
membrane impermeant agent sulfo-NHS-long chain biotin.
E1E2 complexes were immunoprecipitated with MAb H53
or hIgG and subjected to SDS^PAGE and Western blotting
using streptavidin^HRP for detection of biotinylated proteins.
Total HCV glycoproteins were visualized by scanning nitro-
Fig. 3. Subcellular fractionation of HEK 293T cells transfected with pE1E2. Twenty-four hours after transfection, cells were homogenized and
a post-nuclear supernatant applied to a 10^24% iodixanol gradient and ultracentrifuged for 90 min. Fractions were collected from the bottom
of the tube (left) and analyzed in reducing SDS^PAGE and Western blot assay for the presence of calnexin, giantin or E1 (A4) and E2 (A11).
The direction of sedimentation is right to left.
Fig. 4. Cell surface biotinylation of HEK 293T cells transfected with pE1E2. A: Following surface biotinylation, E2 was immunoprecipitated
with MAb H53, hIgG or irrelevant MAb 9E10. Samples were analyzed on non-reducing (NR) and reducing (R) SDS^PAGE followed by West-
ern blotting. Biotinylated proteins were visualized with avidin^HRP and ECL detection. B: pE1E2- (lanes U, H, F) or cDNA4- (lane C) trans-
fected cells were pulse-chase-labelled with [35S]Met/Cys followed by surface biotinylation. E1 and E2 were immunoprecipitated with hIgG and
deglycosylated with endoglycosidase H (H), PNGase F (F) or untreated (U and C). Samples were analyzed in reducing SDS^PAGE followed
by Western blotting. Following visualization of biotinylated proteins with avidin^HRP and ECL, blots were phosphorimaged to examine total
immunoprecipitated protein. C: Surface-expressed E2 is present in a complex with E1. HEK 293T cells were transfected with pE1E2H77c and
24 h later surface-expressed proteins biotinylated. Cells were lysed and applied to avidin-agarose, then subjected to reducing SDS^PAGE and
Western blotting. E1 and E2 were detected by ECL using MAbs A4 and A11, and rabbit anti-mouse HRP.
FEBS 27396 18-6-03 Cyaan Magenta Geel Zwart
H.E. Drummer et al./FEBS Letters 546 (2003) 385^390388
cellulose membranes in a phosphorimager following the ECL
procedure. Both H53 and hIgG immunoprecipitated biotinyl-
ated E2 (Fig. 4A). This E2 band migrated close to its expected
monomer position in non-reducing SDS^PAGE, consistent
with the absence of covalently linked E2 aggregates (Fig.
4A). Biotin-E2 was found to be endoglycosidase H resistant
suggesting that it transits through the trans-Golgi network;
PNGase F reduced the majority of biotin-E2 to its backbone
molecular weight of 40 kDa (Fig. 4B). In contrast, metabol-
ically labelled E1 and E2 remained sensitive to endoglycosi-
dase H suggesting that the majority of E1 and E2 is retained
in the ER (Fig. 4B). Direct biotinylation of E1 at the cell
surface was di⁄cult to achieve, the anti-E1 MAb A4 co-pre-
cipitating substantial amounts of biotin-E2 and a very faint
band corresponding to E1 (data not shown). However, evi-
dence that E1 was complexed with E2 at the cell surface was
obtained by using avidin-agarose to pull down biotinylated E2
before detection of E1 with MAb A4 in immunoblot (Fig.
4C). This result suggests that E2 may obscure E1 from bio-
tinylation within the cell surface-localized complex. E1E2 sur-
face expression was also observed for pCE1E2, pCE1E2p7
and pE1E2p7 vectors indicating that the presence of the other
structural proteins did not a¡ect E1E2 translocation (data not
shown).
3.4. HIV-1 particles pseudotyped with surface-localized E1E2
are entry-competent
In order to investigate if surface-localized E1E2 could me-
diate viral entry, we produced E1E2-pseudotyped HIV-1 lu-
ciferase reporter virus and tested its ability to establish a sin-
gle cycle of replication in Huh7 cells. HEK 293T cells were co-
transfected with pE1E2H77c and the HIV-1 luciferase report-
er vector, NL4-3.LUC.R-E-. NL4-3.LUC.R-E- is derived
from the pNL4-3 proviral clone and contains the ¢re£y lucif-
erase open reading frame in place of nef but lacks functional
vpr and env [16]. We ¢rst con¢rmed the production of partic-
ulate E1E2 (Fig. 5A) and HIV-1 structural proteins, Pr55Gag
and p24Gag (Fig. 5B) by sedimenting pseudotyped particles
through a sucrose cushion prior to SDS^PAGE and Western
blotting with MAb A4/A11 mixture or anti-p24 MAb 183.
The particulate E2 was partially resistant to endoglycosidase
H (Fig. 5C) consistent with the incorporation of cell surface-
localized E1E2 complex into HIV-1, which assembles and
buds at the plasma membrane. However, E1 appeared to re-
main sensitive to deglycosylation with endoglycosidase H
(Fig. 5C). We next tested if E1E2-HIV-1 pseudotypes were
entry-competent. Filtered supernatants from co-transfected
HEK 293T cells were applied to Huh7 cells and luciferase
reporter expression assayed 72 h later. Fig. 5D shows that
E1E2-HIV-1 pseudotypes gave rise to substantial luciferase
activity when compared to the controls, HIV-1 pseudotyped
with E2 alone or lacking envelope glycoprotein. These results
indicate that E1E2-HIV-1 pseudotypes can mediate viral entry
resulting in reporter gene expression. These data also indicate
that surface-expressed E1E2 heterodimers are indeed function-
al.
4. Discussion
Previous studies of HCV glycoproteins have focussed on
intracellular E1E2 forms due to observations indicating that
they are retained in an ER- or cis-Golgi-derived compartment
[5^8]. Intracellular forms of E1E2 are heterogeneous compris-
ing non-covalently associated E1E2 heterodimers together
with covalently associated aggregates [4,17,19]. In addition,
a signi¢cant proportion of non-covalent complexes are asso-
ciated with ER chaperones BiP and calnexin [4]. These char-
acteristics have hampered rigorous investigations of E1E2
structure and function. In this study, we found that the ma-
jority of E1 and E2 expressed in transiently transfected cells
are indeed ER-associated. However, a signi¢cant proportion
of E1 and E2 were also detected in non-ER compartments
and at the cell surface indicating that the ER retention is
not absolute. The detection of surface-expressed E2 may
Fig. 5. Surface-localized E1E2 heterodimers are incorporated into retroviral pseudoparticles and mediate receptor binding and entry into Huh7
cells. 293T cells were co-transfected with pE1E2H77c and NL4-3.LUC.R-E-. Supernatants containing E1E2-pseudotyped retroviral particles
were partially puri¢ed on 20% sucrose cushions and protein content analyzed in reducing SDS^PAGE and Western blotting with (A) MAbs
A4 and A11 or, (B) HIV-1 p24 speci¢c MAb 183. C: Carbohydrate content of HCV-pseudotyped retroviral particles. Partially puri¢ed particles
were either untreated (U) or deglycosylated with endoglycosidase H (H) or PNGase F (F). E1 and E2 were detected in Western blotting with
MAbs A4 and A11. D: Supernatants containing HCV-pseudotyped retroviral particles were applied to Huh7 cells and 3 days later luciferase
activity quantitated in a luminometer. Data shown are the meanTS.D. from triplicate transfections and are representative of two independent
assays.
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have been facilitated by the use of sensitive detection methods
including surface biotinylation and £uorescence microscopy
employing a high-intensity £uorophore (Alexa 488). Further-
more, the use of iodixanol instead of sucrose in fractionation
experiments revealed the presence of E1E2 in non-ER or non-
cis-Golgi compartments. Unlike sucrose, iodixanol allows sub-
cellular fractionation under isotonic conditions thereby limit-
ing disruption to organelles. Such techniques have not been
used previously to study E1E2 localization.
Whereas surface-localized E2 was readily modi¢ed by the
membrane-impermeable biotinylation reagent, surface-bio-
tinylated E1 was not easily detected even after immunoprecip-
itation with the high a⁄nity anti-E1 MAb A4. However, sig-
ni¢cant amounts of E1 were co-precipitated by avidin-agarose
in a complex with biotinylated E2. These data suggest that in
surface-localized complexes, E1 is shielded by E2, precluding
E1 biotinylation. This relationship between E1 and E2 is rem-
iniscent of the organization of £avivirus glycoproteins where
the large envelope protein E shields the small envelope protein
M [20,21].
We and others have produced entry-competent retrovirus
particles pseudotyped with E1E2 heterodimer [22]. As retro-
viruses assemble and bud at the plasma membrane, these ¢nd-
ings are entirely consistent with our observation that E1E2
complexes are surface-expressed. Moreover, the results pre-
sented here and elsewhere [22] indicate that surface-localized
E1E2 is functional because it has the capacity to mediate
receptor-binding and membrane fusion when incorporated
into pseudovirions. The absence of complex carbohydrate
on E1, despite maturation through the secretory pathway,
may also be due to E2 shielding E1 from carbohydrate mod-
i¢cation enzymes in a correctly folded heterodimeric complex.
We found that surface-localized E1E2 was present exclusively
as non-covalently associated heterodimers, in contrast to the
heterogeneous nature of intracellular forms. The HCV glyco-
proteins may therefore enter distinct folding pathways where-
by ER retention signals are negated in a small proportion of
non-covalently associated E1E2 complexes that proceed via
the secretory pathway to the cell surface. The HCV matura-
tion pathway may therefore share some characteristics with
that of £aviviruses where the majority of viral proteins remain
associated with the ER and relatively few assembled particles
enter the secretory pathway prior to budding [23]. It would
now be of interest to examine the subcellular localization and
cell surface distribution of E1 and E2 in systems that may
more closely resemble HCV infection such as full-length
HCV replicons.
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